Announced Tue, 7 Jul · 19:19 IST
Routine filing: Depository compliance certificate for Q1 FY27
Compliance View source PDF
COHANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.2%1-day move
₹440.00
prior close
₹437.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.5+0.7+0.1-0.8+0.2+2.6+1.9-0.8-1.4+1.0————
Up moveDown movePending
AI summary
Cohance Lifesciences submitted a Regulation 74(5) certificate to NSE and BSE for the quarter ended 30 June 2026. KFin Technologies, the company's Registrar and Share Transfer Agent, confirmed that details of securities dematerialized and rematerialized during the quarter have been furnished to the stock exchanges. This is a standard quarterly compliance requirement under SEBI depository regulations.
Likely market impact
No impact on shareholders. This is a routine regulatory filing with no bearing on stock price or business operations.